| 标题 |
[高分]
Percentage of patients with type 2 diabetes and baseline HbA1c ≥7.5% treated with once weekly dulaglutide, or exenatide twice daily, achieving HbA1c decrease of ≥1% and weight loss of ≥3% at 26 weeks in the Assessment of Weekly AdministRation of dulaglutide in Diabetes (AWARD)-1 and -5 studies |
| 网址 | |
| DOI | |
| 其它 |
期刊:Diabetologie und Stoffwechsel 作者:O Adetunji; A Tahbaz; C Nicolay; K Khunti 出版日期:2015 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)